Ben Boursi

4.5k total citations
107 papers, 2.0k citations indexed

About

Ben Boursi is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Ben Boursi has authored 107 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 39 papers in Surgery and 26 papers in Molecular Biology. Recurrent topics in Ben Boursi's work include Pancreatic and Hepatic Oncology Research (13 papers), Colorectal Cancer Treatments and Studies (13 papers) and Colorectal Cancer Screening and Detection (12 papers). Ben Boursi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), Colorectal Cancer Treatments and Studies (13 papers) and Colorectal Cancer Screening and Detection (12 papers). Ben Boursi collaborates with scholars based in Israel, United States and Australia. Ben Boursi's co-authors include Yu‐Xiao Yang, Ronac Mamtani, Kevin Haynes, Ido Lurie, Nadir Arber, Bruce J. Giantonio, Hanan Guzner‐Gur, Yochai Wolf, Stephen J. Blake and Ofer Margalit and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ben Boursi

102 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ben Boursi Israel 26 886 802 397 324 293 107 2.0k
Dawei Wu China 26 681 0.8× 527 0.7× 486 1.2× 491 1.5× 250 0.9× 111 2.1k
Manisha Bhutani United States 27 1.3k 1.5× 1.0k 1.3× 345 0.9× 300 0.9× 250 0.9× 144 2.8k
Takuma Higurashi Japan 26 518 0.6× 689 0.9× 775 2.0× 394 1.2× 257 0.9× 114 2.3k
Xue Wang China 26 634 0.7× 724 0.9× 383 1.0× 399 1.2× 484 1.7× 124 2.1k
Haibo Qiu China 23 907 1.0× 532 0.7× 540 1.4× 936 2.9× 455 1.6× 141 2.6k
Keun-Young Yoo South Korea 27 573 0.6× 751 0.9× 186 0.5× 176 0.5× 330 1.1× 82 2.1k
Antonella Zucchetto Italy 34 1.2k 1.4× 648 0.8× 342 0.9× 368 1.1× 549 1.9× 92 3.0k
Seri Hong South Korea 19 549 0.6× 297 0.4× 275 0.7× 434 1.3× 185 0.6× 47 1.5k
Anne Boutten France 28 352 0.4× 872 1.1× 325 0.8× 644 2.0× 195 0.7× 65 3.0k

Countries citing papers authored by Ben Boursi

Since Specialization
Citations

This map shows the geographic impact of Ben Boursi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Boursi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Boursi more than expected).

Fields of papers citing papers by Ben Boursi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Boursi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Boursi. The network helps show where Ben Boursi may publish in the future.

Co-authorship network of co-authors of Ben Boursi

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Boursi. A scholar is included among the top collaborators of Ben Boursi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Boursi. Ben Boursi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Margalit, Ofer, Amos Stemmer, William J. Chapin, et al.. (2024). Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients. European Journal of Cancer. 212. 114336–114336. 4 indexed citations
3.
Halpern, Naama, Ben Boursi, Einat Shacham‐Shmueli, et al.. (2023). Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer. Oncology and Therapy. 11(4). 513–519.
4.
Davidov, Yana, Mariya Likhter, Yael Inbar, et al.. (2023). Atezolizumab and bevacizumab in advanced hepatocellular carcinoma: Real-world data.. Journal of Clinical Oncology. 41(16_suppl). e16167–e16167.
5.
Margalit, Ofer, Einat Shacham‐Shmueli, Yu‐Xiao Yang, et al.. (2023). Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal Adenocarcinoma. Cancer Investigation. 41(8). 734–738. 1 indexed citations
6.
Laks, Shachar, Mohammad Adileh, Eyal Mor, et al.. (2022). Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Elderly is Safe and Effective. Journal of Surgical Research. 279. 739–747. 2 indexed citations
7.
Ben‐Yaacov, Almog, Mohammad Adileh, Einat Shacham‐Shmueli, et al.. (2022). Outcomes of Stable Lung Colorectal Metastases on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Journal of Gastrointestinal Surgery. 26(8). 1724–1731.
8.
Shacham‐Shmueli, Einat, Ofir Morag, Ofer Margalit, et al.. (2022). Single-Fraction Celiac Plexus Radiosurgery: A Preliminary Proof-of-Concept Phase 2 Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 113(3). 588–593. 10 indexed citations
9.
Harel, Michal, Shun Yu, Ettai Markovits, et al.. (2021). Clinical Proteomics of Metastatic Melanoma Reveals Profiles of Organ Specificity and Treatment Resistance. Clinical Cancer Research. 27(7). 2074–2086. 14 indexed citations
10.
Assaf, Dan, Eyal Mor, Shachar Laks, et al.. (2021). The pattern of peritoneal colorectal metastasis predicts survival after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. European Journal of Surgical Oncology. 48(1). 197–203. 3 indexed citations
11.
Wang, Louise, Frank I. Scott, Ben Boursi, et al.. (2021). Cost-Effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy Among Patients With New-Onset Diabetes. Clinical Gastroenterology and Hepatology. 20(9). 1997–2004.e7. 18 indexed citations
12.
Goldman, Adam, David Bomze, Rachel Dankner, et al.. (2020). Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre‐COVID‐19 reports. British Journal of Clinical Pharmacology. 87(3). 1432–1442. 42 indexed citations
13.
Lawrence, Yaacov Richard, Ofir Morag, D. Alezra, et al.. (2019). Abstract CT147: Celiac plexus radiosurgery a new palliative modality for upper gastrointestinal malignancies - final quality of life results from a proof-of-concept clinical trial. Cancer Research. 79(13_Supplement). CT147–CT147. 1 indexed citations
14.
Eshet, Yael, Erez N. Baruch, Ronnie Shapira‐Frommer, et al.. (2018). Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case–Control Study. Cancer Immunology Research. 6(12). 1453–1458. 46 indexed citations
15.
Boursi, Ben, Kevin Haynes, Ronac Mamtani, & Yu‐Xiao Yang. (2016). An association between newly diagnosed cutaneous T cell lymphoma and prior impetigo: a nested case–control study. Archives of Dermatological Research. 308(9). 661–664. 2 indexed citations
16.
Mamtani, Ronac, James D. Lewis, Frank I. Scott, et al.. (2016). Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study. PLoS Medicine. 13(4). e1002007–e1002007. 51 indexed citations
17.
Mamtani, Ronac, Kevin Haynes, Ben Boursi, et al.. (2014). Validation of a Coding Algorithm to Identify Bladder Cancer and Distinguish Stage in an Electronic Medical Records Database. Cancer Epidemiology Biomarkers & Prevention. 24(1). 303–307. 15 indexed citations
18.
Gottfried, Maya, Avivit Peer, Avivit Neumann, et al.. (2014). Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factors.. PubMed. 16(6). 347–51. 9 indexed citations
19.
Keizman, Daniel, Maya Ish‐Shalom, Роберто Пили, et al.. (2012). Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma. European Journal of Cancer. 48(7). 1031–1037. 42 indexed citations
20.
Wasserman, Asaf, et al.. (2009). Prognostic Significance of Serum Uric Acid in Patients Admitted to the Department of Medicine. The American Journal of the Medical Sciences. 339(1). 15–21. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dawei Wu Breakdown of academic impact, for papers by Manisha Bhutani Breakdown of academic impact, for papers by Takuma Higurashi Breakdown of academic impact, for papers by Xue Wang Breakdown of academic impact, for papers by Haibo Qiu Breakdown of academic impact, for papers by Keun-Young Yoo Breakdown of academic impact, for papers by Antonella Zucchetto Breakdown of academic impact, for papers by Seri Hong Breakdown of academic impact, for papers by Anne Boutten
Rankless by CCL
2026